AT365575B - Verfahren zur herstellung von neuen pyrrolidonen sowie deren physiologisch vertraeglichen metall- oder aminsalzen - Google Patents
Verfahren zur herstellung von neuen pyrrolidonen sowie deren physiologisch vertraeglichen metall- oder aminsalzenInfo
- Publication number
- AT365575B AT365575B AT0467976A AT467976A AT365575B AT 365575 B AT365575 B AT 365575B AT 0467976 A AT0467976 A AT 0467976A AT 467976 A AT467976 A AT 467976A AT 365575 B AT365575 B AT 365575B
- Authority
- AT
- Austria
- Prior art keywords
- pyrrolidones
- amine salts
- physiologically compatible
- producing new
- compatible metal
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002184 metal Substances 0.000 title 1
- 150000004040 pyrrolidinones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752528664 DE2528664A1 (de) | 1975-06-27 | 1975-06-27 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA467976A ATA467976A (de) | 1981-06-15 |
| AT365575B true AT365575B (de) | 1982-01-25 |
Family
ID=5950059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0467976A AT365575B (de) | 1975-06-27 | 1976-06-25 | Verfahren zur herstellung von neuen pyrrolidonen sowie deren physiologisch vertraeglichen metall- oder aminsalzen |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS525764A (enExample) |
| AT (1) | AT365575B (enExample) |
| BE (1) | BE843505A (enExample) |
| CH (1) | CH623809A5 (enExample) |
| DE (1) | DE2528664A1 (enExample) |
| DK (1) | DK287476A (enExample) |
| ES (1) | ES449095A1 (enExample) |
| FR (1) | FR2316943A1 (enExample) |
| GB (1) | GB1553595A (enExample) |
| IL (1) | IL49916A0 (enExample) |
| LU (1) | LU75235A1 (enExample) |
| NL (1) | NL7606773A (enExample) |
| SE (1) | SE7607331L (enExample) |
| ZA (1) | ZA763802B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE423813B (sv) * | 1976-08-06 | 1982-06-07 | Pfizer | Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper |
| US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
| OA12117A (en) | 1999-12-22 | 2006-05-04 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis. |
| WO2002024647A1 (en) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| NZ525164A (en) | 2000-11-27 | 2005-04-29 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis |
| BR0211201A (pt) | 2001-07-16 | 2004-07-13 | Hoffmann La Roche | Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero |
| ES2289140T3 (es) | 2001-07-16 | 2008-02-01 | F. Hoffmann-La Roche Ag | Derivados de 2-pirrolidona como agonistas de prostanoide. |
| TWI313608B (en) | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
| BR0308738A (enExample) * | 2002-03-18 | 2005-01-11 | ||
| US6573294B1 (en) | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| CN1735597A (zh) | 2003-01-10 | 2006-02-15 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素激动剂的2－哌啶酮衍生物 |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US9440919B2 (en) | 2012-07-19 | 2016-09-13 | Cayman Chemical Company, Inc. | Difluorolactam compositions for EP4-mediated osteo related diseases and conditions |
| US9676712B2 (en) | 2013-03-15 | 2017-06-13 | Cayman Chemical Company, Inc. | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions |
| JP6317807B2 (ja) | 2013-03-15 | 2018-04-25 | ケイマン ケミカル カンパニー， インコーポレーテッド | Ｅｐ４媒介性の疾病及び病態の治療に使用するためのｅｐ４受容体選択性アゴニストとしてのラクタム化合物 |
| WO2014144500A2 (en) | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
| AU2014290512A1 (en) | 2013-07-19 | 2015-11-12 | Cayman Chemical Company, Inc. | Methods, systems, and compositions for promoting bone growth |
-
1975
- 1975-06-27 DE DE19752528664 patent/DE2528664A1/de not_active Withdrawn
-
1976
- 1976-06-22 NL NL7606773A patent/NL7606773A/xx not_active Application Discontinuation
- 1976-06-22 ES ES449095A patent/ES449095A1/es not_active Expired
- 1976-06-24 SE SE7607331A patent/SE7607331L/xx unknown
- 1976-06-24 CH CH809976A patent/CH623809A5/de not_active IP Right Cessation
- 1976-06-24 LU LU75235A patent/LU75235A1/xx unknown
- 1976-06-25 DK DK287476A patent/DK287476A/da unknown
- 1976-06-25 AT AT0467976A patent/AT365575B/de active
- 1976-06-25 IL IL49916A patent/IL49916A0/xx unknown
- 1976-06-25 GB GB26564/76A patent/GB1553595A/en not_active Expired
- 1976-06-25 ZA ZA763802A patent/ZA763802B/xx unknown
- 1976-06-26 JP JP51075954A patent/JPS525764A/ja active Pending
- 1976-06-28 BE BE168390A patent/BE843505A/xx not_active IP Right Cessation
- 1976-06-28 FR FR7619563A patent/FR2316943A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ATA467976A (de) | 1981-06-15 |
| GB1553595A (en) | 1979-09-26 |
| FR2316943A1 (fr) | 1977-02-04 |
| DE2528664A1 (de) | 1977-01-13 |
| ZA763802B (en) | 1977-05-25 |
| JPS525764A (en) | 1977-01-17 |
| NL7606773A (nl) | 1976-12-29 |
| ES449095A1 (es) | 1977-12-16 |
| FR2316943B1 (enExample) | 1978-11-03 |
| BE843505A (fr) | 1976-12-28 |
| DK287476A (da) | 1976-12-28 |
| SE7607331L (sv) | 1976-12-28 |
| CH623809A5 (en) | 1981-06-30 |
| LU75235A1 (enExample) | 1977-03-16 |
| IL49916A0 (en) | 1976-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT340895B (de) | Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen | |
| AT359494B (de) | Verfahren zur herstellung von neuen pyridinyl- 2(1h)-pyridinonen und deren saeureadditions- salzen | |
| AT361937B (de) | Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen | |
| AT365575B (de) | Verfahren zur herstellung von neuen pyrrolidonen sowie deren physiologisch vertraeglichen metall- oder aminsalzen | |
| AT358555B (de) | Verfahren zur herstellung von neuen n-amino- alkyl-2-methoxy-benzolsulfonamiden sowie deren saeureadditionssalzen | |
| AT359522B (de) | Verfahren zur herstellung von neuen 6-amino- alkylaminouracilen sowie deren saeureadditions- salzen | |
| AT362366B (de) | Verfahren zur herstellung von neuen 5-methyl- -isoxazol-4-carbonsaeureamiden sowie deren salzen | |
| AT347463B (de) | Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren saeureadditions- salzen | |
| AT346303B (de) | Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und deren saeure- additionssalzen | |
| AT363923B (de) | Verfahren zur herstellung von neuen 8-amino-alkyltetracyclononanen und von deren saeureadditionssalzen | |
| ATA606377A (de) | Verfahren zur herstellung von neuen 1-disubstiuierten phenoxy-2-hydroxy-3-diphenylmethylamino- und -3- (9'-fluorenylamino)-propanen sowie deren saureadditionssalzen | |
| AT361904B (de) | Verfahren zur herstellung von neuen 3-anilino- aethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen | |
| AT359474B (de) | Verfahren zur herstellung von neuen 5-phenoxy- 6,7,8,9-tetrahydro-cyclohepten-7-aminen und von deren saeureadditionssalzen | |
| AT340896B (de) | Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| ATA328376A (de) | Verfahren zur herstellung von neuen 3-aminomethyl-2-phenylbicyclo(2,2,2)octanen und deren saureadditionssalzen | |
| AT342565B (de) | Verfahren zur herstellung von neuen 3,4-dichlorphenon-o-(2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| AT360033B (de) | Verfahren zur herstellung von neuen tetrahydro- -s-triazinthionen und deren saeure- additionssalzen | |
| AT340897B (de) | Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| AT360010B (de) | Verfahren zur herstellung von neuen azabicyclo- alkanen und deren physiologisch vertraeglichen saeureadditionssalzen | |
| AT340894B (de) | Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen | |
| AT369740B (de) | Verfahren zur herstellung von neuen thiodibenzthiepinen und deren saeureadditionssalzen | |
| AT342021B (de) | Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| AT348979B (de) | Verfahren zur herstellung von neuen 7-aminomethylbenzocycloheptenen und deren saeureadditonssalzen | |
| ATA59280A (de) | Verfahren zur herstellung von neuen 3-anilinoaethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen | |
| ATA214677A (de) | Verfahren zur herstellung von neuen 7,7- -dimethyl-1-aminoalkyl-(2,2,1)-bicycloheptanen und von deren saeureadditionssalzen |